Details
Stereochemistry | RACEMIC |
Molecular Formula | C13H19NO3 |
Molecular Weight | 237.2954 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOc1ccccc1OCC2CNCCO2
InChI
InChIKey=YWPHCCPCQOJSGZ-UHFFFAOYSA-N
InChI=1S/C13H19NO3/c1-2-15-12-5-3-4-6-13(12)17-10-11-9-14-7-8-16-11/h3-6,11,14H,2,7-10H2,1H3
Viloxazine is an antidepressant drug was used to treat patients with depression. Viloxazine inhibits noradrenaline uptake. This drug was approved in some Europe countries, but not in the USA, but then it was discontinued because of competition from other drugs. In the frame of drug repositioning, Viloxazine participated in clinical trials for the treatment of attention deficit hyperactivity disorder. Phase II of trials was successfully passed.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P23975 Gene ID: 6530.0 Gene Symbol: SLC6A2 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/27230580 |
|||
Target ID: P23975 Gene ID: 6530.0 Gene Symbol: SLC6A2 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/27230580 |
PubMed
Title | Date | PubMed |
---|---|---|
[Comparative evaluation of the therapeutic efficacy of the antidepressants adepren, linamiphen and emovit]. | 1986 |
|
Stereochemistry and drug efficacy and development: relevance of chirality to antidepressant and antipsychotic drugs. | 2002 |
|
Simultaneous determination of viloxazine, venlafaxine, imipramine, desipramine, sertraline, and amoxapine in whole blood: comparison of two extraction/cleanup procedures for capillary gas chromatography with nitrogen-phosphorus detection. | 2002 Jul-Aug |
|
Contribution of sleep research to the development of new antidepressants. | 2005 |
|
Development of a solid phase extraction for 13 'new' generation antidepressants and their active metabolites for gas chromatographic-mass spectrometric analysis. | 2005 Dec 9 |
|
Internet-based search of randomised trials relevant to mental health originating in the Arab world. | 2005 Jul 26 |
|
Gastrointestinal bleeding and massive liver damage in neuroleptic malignant syndrome. | 2005 Sep |
|
Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry: a multi-level, single-sample approach. | 2006 Oct 20 |
|
Comparison of electron and chemical ionization modes by validation of a quantitative gas chromatographic-mass spectrometric assay of new generation antidepressants and their active metabolites in plasma. | 2007 Dec 28 |
|
Quantification of tricyclic antidepressants and monoamine oxidase inhibitors by high-performance liquid chromatography-tandem mass spectrometry in whole blood. | 2007 May |
|
Antidepressant drugs for narcolepsy. | 2008 Jan 23 |
|
A prognostic system applicable to patients with resectable liver metastasis from colorectal carcinoma staged by positron emission tomography with [18F]fluoro-2-deoxy-D-glucose: role of primary tumor variables. | 2008 May |
|
Getting the balance right: Established and emerging therapies for major depressive disorders. | 2010 Sep 7 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22454923
100 mg
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
N06AX09
Created by
admin on Fri Jun 25 23:08:57 UTC 2021 , Edited by admin on Fri Jun 25 23:08:57 UTC 2021
|
||
|
WHO-VATC |
QN06AX09
Created by
admin on Fri Jun 25 23:08:57 UTC 2021 , Edited by admin on Fri Jun 25 23:08:57 UTC 2021
|
||
|
NCI_THESAURUS |
C265
Created by
admin on Fri Jun 25 23:08:57 UTC 2021 , Edited by admin on Fri Jun 25 23:08:57 UTC 2021
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
5I5Y2789ZF
Created by
admin on Fri Jun 25 23:08:57 UTC 2021 , Edited by admin on Fri Jun 25 23:08:57 UTC 2021
|
PRIMARY | |||
|
M11448
Created by
admin on Fri Jun 25 23:08:57 UTC 2021 , Edited by admin on Fri Jun 25 23:08:57 UTC 2021
|
PRIMARY | Merck Index | ||
|
3489
Created by
admin on Fri Jun 25 23:08:57 UTC 2021 , Edited by admin on Fri Jun 25 23:08:57 UTC 2021
|
PRIMARY | |||
|
DB09185
Created by
admin on Fri Jun 25 23:08:57 UTC 2021 , Edited by admin on Fri Jun 25 23:08:57 UTC 2021
|
PRIMARY | |||
|
CHEMBL306700
Created by
admin on Fri Jun 25 23:08:57 UTC 2021 , Edited by admin on Fri Jun 25 23:08:57 UTC 2021
|
PRIMARY | |||
|
VILOXAZINE
Created by
admin on Fri Jun 25 23:08:57 UTC 2021 , Edited by admin on Fri Jun 25 23:08:57 UTC 2021
|
PRIMARY | |||
|
256-281-7
Created by
admin on Fri Jun 25 23:08:57 UTC 2021 , Edited by admin on Fri Jun 25 23:08:57 UTC 2021
|
PRIMARY | |||
|
46817-91-8
Created by
admin on Fri Jun 25 23:08:57 UTC 2021 , Edited by admin on Fri Jun 25 23:08:57 UTC 2021
|
PRIMARY | |||
|
D014745
Created by
admin on Fri Jun 25 23:08:57 UTC 2021 , Edited by admin on Fri Jun 25 23:08:57 UTC 2021
|
PRIMARY | |||
|
46817-91-8
Created by
admin on Fri Jun 25 23:08:57 UTC 2021 , Edited by admin on Fri Jun 25 23:08:57 UTC 2021
|
PRIMARY | |||
|
11196
Created by
admin on Fri Jun 25 23:08:57 UTC 2021 , Edited by admin on Fri Jun 25 23:08:57 UTC 2021
|
PRIMARY | RxNorm | ||
|
2820
Created by
admin on Fri Jun 25 23:08:57 UTC 2021 , Edited by admin on Fri Jun 25 23:08:57 UTC 2021
|
PRIMARY | |||
|
5666
Created by
admin on Fri Jun 25 23:08:57 UTC 2021 , Edited by admin on Fri Jun 25 23:08:57 UTC 2021
|
PRIMARY | |||
|
SUB00049MIG
Created by
admin on Fri Jun 25 23:08:57 UTC 2021 , Edited by admin on Fri Jun 25 23:08:57 UTC 2021
|
PRIMARY | |||
|
C152877
Created by
admin on Fri Jun 25 23:08:57 UTC 2021 , Edited by admin on Fri Jun 25 23:08:57 UTC 2021
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)